Free express shipping over $999 · Verified pharmaceuticals · Discreet packaging worldwide
OnlineMeds onlinemeds.org
Account Cart
Skip to order
Prescription only medicine

Afanat 30 mg Tablet

Afatinib Dimaleate 30 mg · Generic equivalent of Gilotrif

Afanat 30 mg Tablet is a trusted medication containing Afatinib, designed for personal use under the guidance of a healthcare professional. Available for prescription-based international supply with discreet worldwide delivery.

Active ingredient
Afatinib Dimaleate
Strength
30 mg
Form
Tablet
Manufacturer
Natco Pharma Ltd.
Made in
India
Prescription
Required
Commonly used forLung Cancer
$79.00 per pack of 28 tablets

Prescription required — upload it at checkout.

Generic equivalent of Gilotrif — up to 80% less than the branded price

Verified pharmacy Genuine medication Tracked shipping Medically reviewed by Harsh Bootwala
Licensed Pharmacy Trust & safety
Licensed Manufacturers Every medicine from a licensed manufacturer
Dedicated Oncology Team Doctor + pharmacist review every order before dispatch
Worldwide Delivery UK · US · AU · EU · NZ — tracked and insured
About this medicine

What is Afanat 30 mg Tablet?

Afatinib is a targeted tablet for non-small cell lung cancer whose cells carry a change (mutation) in the EGFR gene. It is used as a first treatment for metastatic EGFR-mutant lung cancer — including some of the less common mutations — and for squamous lung cancer that has progressed after platinum chemotherapy.

It is a second-generation EGFR inhibitor: it binds permanently to EGFR and its relatives HER2 and HER4, switching off the growth signal that the mutation has jammed on. Because EGFR is also important in skin and the gut lining, diarrhoea and an acne-like rash are very common and are managed with medicines your team will give you from the start.

Afatinib is taken once a day on an empty stomach. Your tumour must have been tested for an EGFR mutation before it is prescribed. It is a prescription-only medicine; a valid prescription must be provided at checkout.

How it works

How does Afatinib work?

EGFR is a receptor on the surface of lung cells that, when activated, tells the cell to grow. In some lung cancers a mutation leaves EGFR permanently switched on, and the tumour depends on that signal. Afatinib enters the cell and forms a permanent bond with the signalling part of EGFR — and of its relatives HER2 and HER4 — so the signal stops and the cancer cell dies. The bond is irreversible, which is why afatinib keeps working between doses. Normal skin and gut cells also use EGFR for day-to-day repair, so rash and diarrhoea are expected side effects rather than allergies.

Covalent binding

Afatinib bonds irreversibly to a cysteine in the kinase pocket of EGFR (ErbB1), HER2 (ErbB2) and HER4 (ErbB4).

Signal cut off

The mutant receptor can no longer activate the growth pathways beneath it (MAPK, PI3K/AKT).

Cell death

EGFR-dependent tumour cells stop dividing and die; the irreversible bond means the block lasts until the cell makes new receptor.

Uses

What is Afatinib used for?

Metastatic non-small cell lung cancer with EGFR exon 19 deletion or exon 21 (L858R) mutation

First-line. Also for certain uncommon EGFR mutations (S768I, L861Q, G719X).

FDA EMA CDSCO
Metastatic squamous non-small cell lung cancer

After progression on platinum-based chemotherapy.

FDA EMA

Only your oncologist can determine whether this medicine is right for your diagnosis. The above is for information only.

Dosage

How to take Afanat 30 mg Tablet

Your oncologist will prescribe your exact dose. The right dose for you depends on your weight, kidney and liver function, and — for some medicines — your genetic test results.

Always take exactly as prescribed. Do not change your dose or stop taking this medicine without speaking to your doctor first, even if you feel well.

Missed a dose? If it is more than 8 hours until the next dose, take the missed dose. Otherwise skip it. Never double up.

With food? Take on an empty stomach — no food for at least three hours before and one hour after. Food reduces absorption. Swallow whole with water.

Important safety information

Safety & warnings

Please read this section before taking Afanat 30 mg Tablet and discuss any concerns with your oncologist.

Common side effects

Side effects affect some people, not everyone. Most are manageable — let your treatment team know about anything that concerns you.

  • Diarrhoea
  • Acne-like rash, dry skin, itching
  • Mouth soreness and ulcers (stomatitis)
  • Nail-fold inflammation (paronychia)
  • Reduced appetite, nausea, weight loss
  • Nosebleeds
  • Conjunctivitis, dry eyes
  • Raised liver enzymes
  • Low potassium (with diarrhoea)

Contact your doctor immediately if you notice:

  • Diarrhoea that is severe, lasts more than two days, or comes with dizziness or reduced urine Contact your team the same day; start loperamide at the first loose stool as instructed and keep drinking fluids. Dehydration and kidney injury can follow.
  • New or worsening breathlessness, cough or fever Seek urgent review — lung inflammation (interstitial lung disease) is rare but serious; afatinib is stopped if confirmed.
  • Yellow skin or eyes, dark urine Contact your doctor immediately — possible liver injury.
  • Painful blistering rash, or rash with fever and mouth ulcers Stop and seek urgent care — severe skin reactions are rare but reported.
  • Eye pain, sudden vision change, severe redness Seek prompt eye assessment — keratitis can occur; do not wear contact lenses if eyes are sore.
  • Breathlessness, swollen ankles, palpitations Seek urgent review — reduced heart function has been reported.
  • Severe abdominal pain Seek urgent care — bowel perforation has been reported rarely.

Important: tell your doctor about these medicines

Taking Afatinib with certain other medicines can be dangerous. Always tell every doctor, dentist, and pharmacist about all medicines you are taking.

  • Strong P-glycoprotein inhibitors (ritonavir, cyclosporine, ketoconazole, itraconazole, erythromycin, verapamil, amiodarone) Major

    Increase afatinib levels.

  • Strong P-glycoprotein inducers (rifampicin, carbamazepine, phenytoin, St John's wort) Major

    Reduce afatinib levels.

  • Live vaccines Major

    Safety not established during active treatment.

Pregnancy & breastfeeding

Afatinib can harm an unborn baby. It should not be used in pregnancy, and women who could become pregnant should use effective contraception during treatment and for at least two weeks after the last dose.

Do not breastfeed during treatment or for two weeks after the last dose.

Effects on human fertility are not established; animal data suggest possible impairment. Discuss fertility preservation before starting if relevant.

For full prescribing information see: FDA prescribing information: Gilotrif (afatinib) — DailyMed

Storage

How to store Afanat 30 mg Tablet

Temperature

Store below 25°C (77°F).

Light & moisture

Keep in the original blister to protect from moisture and light.

Keep away from children

Keep out of the sight and reach of children.

Safe handling

Anticancer medicine: swallow whole, do not crush; wash hands after handling. Return unused tablets to a pharmacy.

Travelling

Carry in the original packaging with your prescription and an oncologist's letter, and take your loperamide with you.

Reviewed for accuracy

Medically reviewed content

Harsh Bootwala

Harsh Bootwala

B.Pharm, M.Pharm

Harsh Bootwala is a licensed clinical pharmacist with 12 years of experience. He holds a B.Pharm and M.Pharm from Bombay University. At OnlineMeds, he reviews medicine and health content to help ensure it is accurate, evidence-based, and easy to understand.

Our commitment to you

How we support oncology patients

We understand that accessing the right cancer medicine can feel overwhelming. Here is what you can expect from us.

Personal oncology support

Every enquiry is reviewed by our oncology doctor and pharmacist team — not an automated system.

Genuine, verified medicine

Sourced exclusively from licensed pharmaceutical manufacturers. Every batch is traceable from origin to your door.

Prescription checked before dispatch

We verify every prescription with our internal medical team. No shortcuts, no exceptions.

Cold-chain logistics

Temperature-sensitive medicines shipped with appropriate packaging to maintain integrity.

Discreet, plain packaging

No pharmacy branding or product name on the outer packaging.

Up to 80% less than branded

Generic oncology medicines contain the same active ingredient as the originator brand — at a fraction of the cost.

FAQ

Frequently asked questions

Is Afatinib Dimaleate the same as Giotrif?

Afatinib Dimaleate is the active ingredient in Giotrif. A generic Afatinib Dimaleate medicine contains the same active ingredient at the same strength and is taken the same way — the main difference is cost. Always use it as prescribed by a licensed medical professional.

Do I need an EGFR test before taking Afanat 30 mg Tablet?

Yes. Afatinib only helps lung cancers that carry an activating EGFR mutation, and your oncologist will have confirmed this on a tumour sample or blood test before prescribing.

[1] FDA prescribing information: Gilotrif (afatinib) — DailyMed

How does Afanat 30 mg Tablet differ from gefitinib, erlotinib or osimertinib?

All target EGFR. Gefitinib and erlotinib bind reversibly; afatinib binds permanently and also blocks HER2 and HER4, which helps against some uncommon mutations. Osimertinib is a third-generation drug that also covers the T790M resistance mutation and reaches the brain. Which is best for you depends on your mutation, prior treatment and availability — your oncologist decides.

[2] NCI Drug Information: Afatinib Dimaleate

Why is diarrhoea so common, and what do I do?

EGFR helps the gut lining renew itself, so blocking it loosens the bowels in most people, usually in the first weeks. Start loperamide at the first loose stool exactly as your team instructs, drink plenty of fluids, and call if it is severe or lasts more than two days. A dose reduction usually settles it without losing effect.

[4] Macmillan Cancer Support: Afatinib (Giotrif)

What about the rash?

An acne-like rash on the face, chest and back is expected. Use fragrance-free moisturiser, sun protection, and the antibiotic cream or tablets your team prescribes. It is not an allergy and it usually improves after the first two months. Tell your team if it blisters or becomes painful.

[4] Macmillan Cancer Support: Afatinib (Giotrif)

Why must Afanat 30 mg Tablet be taken on an empty stomach?

Food lowers absorption significantly. Leave at least three hours after a meal and one hour before the next one, and take it with water.

[1] FDA prescribing information: Gilotrif (afatinib) — DailyMed

Is Afanat 30 mg Tablet the same as Gilotrif / Giotrif?

Afanat 30 mg Tablet contains the same active ingredient, afatinib dimaleate, at the same strength as the originator brand (Gilotrif in the US, Giotrif in Europe). Generic medicines must meet the same regulatory standards for quality, safety and effectiveness. Used as prescribed by a licensed medical professional.

[3] EMA: Giotrif — European public assessment report

Can I wear contact lenses?

Afatinib can dry and irritate the eyes. If your eyes are red, sore or your vision blurs, stop wearing lenses and get them checked promptly — keratitis is uncommon but needs treatment.

[1] FDA prescribing information: Gilotrif (afatinib) — DailyMed

Do I need a prescription to order Afanat 30 mg Tablet?

Yes. Afatinib is prescription-only. Upload your oncologist's prescription at checkout; our pharmacist team reviews it before dispatch. Used as prescribed by a licensed medical professional.

Sources

References

  1. 1. FDA prescribing information: Gilotrif (afatinib) — DailyMed. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=gilotrif U.S. National Library of Medicine. Accessed 13 Sep 2026.
  2. 2. NCI Drug Information: Afatinib Dimaleate. https://www.cancer.gov/about-cancer/treatment/drugs/afatinibdimaleate National Cancer Institute. Accessed 13 Sep 2026.
  3. 3. EMA: Giotrif — European public assessment report. https://www.ema.europa.eu/en/medicines/human/EPAR/giotrif European Medicines Agency. Accessed 13 Sep 2026.
  4. 4. Macmillan Cancer Support: Afatinib (Giotrif). https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/afatinib Accessed 13 Sep 2026.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional — specifically your oncologist — before starting, changing, or stopping any medication. Information is based on NDA #201292, NCI Drug Information, and NHS patient information.
Editorial policy Privacy policy Terms & conditions
Shopping cart
Close
Shop
0 items Cart
My account